Posts by: Isaura Santos

Isaura Santos

Isaura Santos graduated with a BS in Cell and Molecular Biology from Universidade Nova de Lisboa and a MA in Communication, Culture and Information Technologies from University Institute of Lisbon (ISCTE-IUL). Her professional interests include science communication, public awareness of science and communication of science through entertainment.

February 12, 2015February 12, 2015

Free Seminar Offers Info on Stem Cell Treatment Options For RA, Other Chronic Diseases

News, rheumatoid arthritis

The Miami Stem Cell Treatment Center recently announced a series of free public seminars on the use of adult autologous stem cells to address inflammatory and degenerative conditions, which will be offered in February and March. The ... Read more

February 5, 2015February 5, 2015

TiGenix European Patent Issued For Expanded Adipose-Derived Stem Cell Compositions

News

TiGenix NV, a leading bio-pharmaceutical company focused on developing and commercializing new therapeutics based on its proprietary platform of allogeneic expanded adipose-derived stem cells (eASCs) for autoimmune and inflammatory diseases, recently announced the European ... Read more

February 4, 2015February 4, 2015

Ablynx Successfully Opposes Patent Appeal Case By Domantis (GSK)

News

Ablynx recently announced its success in opposing the 2010 appeal lodged by Domantis, a former privately-owned British biotech company now owned by GlaxoSmithKline. Domantis submitted an appeal to the Opposition Division ... Read more

January 13, 2015January 13, 2015

Adalimumab’s First Biosimilar is Launched by Indian Pharmaceutical Company

News

Zydus Cadila launched the world’s first biosimilar of Adalimumab (Enbrel), the largest selling therapy in the world. This event increases the possibility that the up to 12 million people with immune disorders ... Read more

January 8, 2015January 8, 2015

Irvine Stem Cell Treatment Center Offers Free Stem Cell Seminars, Featuring Applications in Rheumatoid Arthritis Treatment

News

Free public seminars on the use of adult stem cells for several degenerative and inflammatory conditions, such as rheumatoid arthritis, are being offered by the Irvine Stem Cell Treatment Center throughout January. The ... Read more

January 6, 2015January 6, 2015

Rheumatoid Arthritis Drug Rituximab Delays Need For Re-treatment from Disease Flares

News

According to recent findings, patients with rheumatoid arthritis (RA) who were treated with rituximab benefit from a delayed need for re-treatment due of a disease flare, which is a common occurrence in chronic diseases such as RA. ... Read more

December 30, 2014December 30, 2014

Depression Slows Down Rheumatoid Arthritis Remission

News

Depression and rheumatoid arthritis (RA) often come together as a vicious cycle that can damage both mental and emotional aspects of a patients’ life. Can it cause physical damage as well? A ... Read more

December 10, 2014December 10, 2014

Phase 3 Trial of Baricitinib in Moderate to Severe Rheumatoid Arthritis Revealed Positive Results

News

Eli Lilly and Company and Incyte Corporation announced that the RA-BEACON Phase 3 study of baricitinib, an investigational drug for RA, improved the ACR20 response (the response that indicates how much a person’s rheumatoid arthritis ... Read more